Modernisation and launch of a new vaccine filling line
Launch of a vaccine active substance production department after general renovation
Establishment of a Research and Development Centre (R&DC)
Creation of the Business Development Department
Establishing the name Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna (Institute of Serum and Vaccine Biotechnology - Joint Stock Company)
Transformation of the production facility into a joint stock company (Polish: Spółka Akcyjna)
Transformation of the Serum and Vaccine Manufacturing Plant into a company wholly owned by the State Treasury
Establishing a new independent unit of the Serum and Vaccine Manufactory BIOMED – Krakow.
Extending the Manufactory’s base in Krakow with the private Serum and Vaccine Production Plant of prof. Odon Bujwid – an associate of Louis Pasteur.
Plant reorganization and an foundation of the Serum and Vaccine Manufactory Unification “BIOMED,” having its seats in Krakow, Warszawa and Lublin.
Starting the vaccine production, among others: vaccine against the exanthematous fever, typhoid fever, pseudo-typhus and dysentery, so-called “Penty.”
Setting up a production team made of people who rendered great service to the Polish science: Tadeusz Korzybski, Jan Kostrzewski, Wlodzimierz Kurylowicz and Stefan Slopek.
Establishing Vaccine Production Plant on the initiative of the director of the Medical Microbiology Institute at Jagiellonian University in Krakow Prof. Zdzislaw Przybylkiewicz, MD, PhD.